Biotech Moderna received the FDA's authorization to conduct a second phase of clinical trials as it works to develop a vaccine against the virus.
"With the goal of starting the mRNA-1273 pivotal Phase 3 study early this summer, Moderna is now preparing to potentially have its first BLA approved as soon as 2021," Bancel said.
"We are accelerating manufacturing scale-up and our partnership with Lonza puts us in a position to make and distribute as many vaccine doses of mRNA-1273 as possible, should it prove to be safe and effective," the statement concluded.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna shares surge after FDA approves coronavirus vaccine for phase 2 trialModerna has received FDA approval for the company's Covid-19 vaccine to continue into the second phase. CNBC's Becky Quick reports.
Read more »
The FDA Has Approved a Coronavirus Vaccine for Phase Two TrialThe FDA has given Moderna the green light to enter into phase two of trials with its vaccine against the novel coronavirus that causes COVID-19
Read more »
FDA Authorizes First-Ever Crispr Application For COVID-19 Coronavirus TestThe FDA granted its first-ever emergency use authorization for the gene-editing technology Crispr—greenlighting a coronavirus diagnostic test developed by Cambridge, Massachusetts-based Sherlock Biosciences
Read more »
FDA Approves Diabetes Drug for Type of Heart FailureThe FDA today approved a new use for the diabetes drug, dapagliflozin (Farxiga), to reduce the risk of a hospital stay or death in people who have a type of heart failure.
Read more »
The FDA Has Approved a Coronavirus Vaccine for Phase Two TrialThe FDA has given Moderna the green light to enter into phase two of trials with its vaccine against the novel coronavirus that causes COVID-19
Read more »
Moderna shares surge after FDA approves coronavirus vaccine for phase 2 trialModerna has received FDA approval for the company's Covid-19 vaccine to continue into the second phase. CNBC's Becky Quick reports.
Read more »